Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Factors affecting the benefit of insulin dose intensification in people with Type 2 diabetes: an analysis from the OpT2mise randomized trial.

Schütz-Fuhrmann I, Castañeda J, Reznik Y, Aronson R, Conget I, Liabat S, Runzis S, de Portu S, Cohen O.

Diabet Med. 2017 Feb;34(2):291-292. doi: 10.1111/dme.13279. No abstract available.

PMID:
27770589
2.

Type 1 diabetes in older adults: Comparing treatments and chronic complications in the United States T1D Exchange and the German/Austrian DPV registries.

Weinstock RS, Schütz-Fuhrmann I, Connor CG, Hermann JM, Maahs DM, Schütt M, Agarwal S, Hofer SE, Beck RW, Holl RW; T1D Exchange Clinic Network.; DPV Initiative..

Diabetes Res Clin Pract. 2016 Dec;122:28-37. doi: 10.1016/j.diabres.2016.09.024. Epub 2016 Oct 4.

PMID:
27764721
3.

[Insulin pump therapy in children, adolescents and adults].

Stadler M, Zlamal-Fortunat S, Schütz-Fuhrmann I, Rami-Merhar B, Fröhlich-Reiterer E, Hofer S, Mader J, Resl M, Kautzky-Willer A, Weitgasser R, Prager R, Bischof M.

Wien Klin Wochenschr. 2016 Apr;128 Suppl 2:S188-95. doi: 10.1007/s00508-016-0966-0. Review. German.

PMID:
27052245
4.

[CGM-Continuous Glucose Monitoring--Statement of the Austrian Diabetes Association].

Schütz-Fuhrmann I, Rami-Merhar B, Hofer S, Stadler M, Bischof M, Zlamal-Fortunat S, Laimer M, Weitgasser R, Prager R.

Wien Klin Wochenschr. 2016 Apr;128 Suppl 2:S184-7. doi: 10.1007/s00508-016-0958-0. German.

PMID:
27052243
5.

Variability of Basal Rate Profiles in Insulin Pump Therapy and Association with Complications in Type 1 Diabetes Mellitus.

Laimer M, Melmer A, Mader JK, Schütz-Fuhrmann I, Engels HR, Götz G, Pfeifer M, Hermann JM, Stettler C, Holl RW.

PLoS One. 2016 Mar 3;11(3):e0150604. doi: 10.1371/journal.pone.0150604. eCollection 2016.

6.

Reductions in A1C with pump therapy in type 2 diabetes are independent of C-peptide and anti-glutamic acid decarboxylase antibody concentrations.

Reznik Y, Huang S; OpT2mise Study Group..

Diabetes Technol Ther. 2014 Nov;16(11):816-8. doi: 10.1089/dia.2014.0261. Epub 2014 Sep 5. No abstract available.

7.

Impact of continuous glucose monitoring on quality of life, treatment satisfaction, and use of medical care resources: analyses from the SWITCH study.

Hommel E, Olsen B, Battelino T, Conget I, Schütz-Fuhrmann I, Hoogma R, Schierloh U, Sulli N, Gough H, Castañeda J, de Portu S, Bolinder J; SWITCH Study Group..

Acta Diabetol. 2014 Oct;51(5):845-51. doi: 10.1007/s00592-014-0598-7. Epub 2014 Jul 19.

8.

Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial.

Reznik Y, Cohen O, Aronson R, Conget I, Runzis S, Castaneda J, Lee SW; OpT2mise Study Group..

Lancet. 2014 Oct 4;384(9950):1265-72. doi: 10.1016/S0140-6736(14)61037-0. Epub 2014 Jul 2.

PMID:
24998009
9.

Adherence to clinical care guidelines for cystic fibrosis-related diabetes in 659 German/Austrian patients.

Scheuing N, Berger G, Bergis D, Gohlke B, Konrad K, Laubner K, Lilienthal E, Moser C, Schütz-Fuhrmann I, Thon A, Holl RW; German/Austrian Diabetes Prospective Documentation (DPV) Initiative..

J Cyst Fibros. 2014 Dec;13(6):730-6. doi: 10.1016/j.jcf.2014.05.006. Epub 2014 Jun 7.

10.

[Guidelines for insulin pump therapy in children and adults].

Stadler M, Zlamal-Fortunat S, Schütz-Fuhrmann I, Rami-Merhar B, Schober E, Kautzky-Willer A, Weitgasser R, Prager R, Bischof M.

Wien Klin Wochenschr. 2012 Dec;124 Suppl 2:123-8. doi: 10.1007/s00508-012-0287-x. German.

PMID:
23371330
11.

[CGM-continuous glucose monitoring - statement of the Austrian Diabetes Association].

Schütz-Fuhrmann I, Schober E, Rami B, Stadler M, Bischof M, Fortunat S, Laimer M, Weitgasser R, Prager R.

Wien Klin Wochenschr. 2012 Dec;124 Suppl 2:120-2. doi: 10.1007/s00508-012-0291-1. German.

PMID:
23250473
12.

The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial.

Battelino T, Conget I, Olsen B, Schütz-Fuhrmann I, Hommel E, Hoogma R, Schierloh U, Sulli N, Bolinder J; SWITCH Study Group..

Diabetologia. 2012 Dec;55(12):3155-62. doi: 10.1007/s00125-012-2708-9. Epub 2012 Sep 11.

13.

The SWITCH study (sensing with insulin pump therapy to control HbA(1c)): design and methods of a randomized controlled crossover trial on sensor-augmented insulin pump efficacy in type 1 diabetes suboptimally controlled with pump therapy.

Conget I, Battelino T, Giménez M, Gough H, Castañeda J, Bolinder J; SWITCH Study Group..

Diabetes Technol Ther. 2011 Jan;13(1):49-54. doi: 10.1089/dia.2010.0107.

PMID:
21175271

Supplemental Content

Loading ...
Support Center